The Agent Orange Relief Act of 2025 expands federal support for individuals harmed by exposure to Agent Orange during the Vietnam War, affecting U.S. veterans, Vietnamese Americans, and their descendants. The bill removes gender restrictions from VA benefits for birth defects in children of Vietnam veterans, extending coverage to children of male veterans who currently receive benefits only for spina bifida—aligning them with broader protections already available to children of female veterans. The legislation directs the Department of Health and Human Services to fund health assessments of Vietnamese Americans potentially exposed to Agent Orange and establish treatment centers in communities with large Vietnamese American populations, while the VA must conduct research on the intergenerational health effects of exposure and survey veterans' children to identify gaps in care. Both agencies must complete implementation plans within 180 days and fully implement the bill's provisions within 18 months of enactment, with quarterly progress reports to Congress thereafter. No specific funding amounts are provided in the bill's text.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.